CA2381830A1 - Composes comprenant un extrait de thylakoides pouvant etre utilises pour moduler le processus d'inflammation - Google Patents

Composes comprenant un extrait de thylakoides pouvant etre utilises pour moduler le processus d'inflammation Download PDF

Info

Publication number
CA2381830A1
CA2381830A1 CA002381830A CA2381830A CA2381830A1 CA 2381830 A1 CA2381830 A1 CA 2381830A1 CA 002381830 A CA002381830 A CA 002381830A CA 2381830 A CA2381830 A CA 2381830A CA 2381830 A1 CA2381830 A1 CA 2381830A1
Authority
CA
Canada
Prior art keywords
inflammation
inflammatory
extract
thylakoid
tnf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002381830A
Other languages
English (en)
Inventor
Marc Purcell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Purecell Technologies Inc
Original Assignee
Purecell Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purecell Technologies Inc filed Critical Purecell Technologies Inc
Priority to CA002381830A priority Critical patent/CA2381830A1/fr
Priority to AT02745002T priority patent/ATE304860T1/de
Priority to DE60206270T priority patent/DE60206270T2/de
Priority to US10/482,797 priority patent/US7329423B2/en
Priority to CA002450833A priority patent/CA2450833C/fr
Priority to JP2003510053A priority patent/JP4988144B2/ja
Priority to PCT/CA2002/001009 priority patent/WO2003004042A1/fr
Priority to EP02745002A priority patent/EP1401463B1/fr
Publication of CA2381830A1 publication Critical patent/CA2381830A1/fr
Priority to JP2009221131A priority patent/JP2009298810A/ja
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pain & Pain Management (AREA)
CA002381830A 2001-07-02 2002-04-15 Composes comprenant un extrait de thylakoides pouvant etre utilises pour moduler le processus d'inflammation Abandoned CA2381830A1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
CA002381830A CA2381830A1 (fr) 2002-04-15 2002-04-15 Composes comprenant un extrait de thylakoides pouvant etre utilises pour moduler le processus d'inflammation
AT02745002T ATE304860T1 (de) 2001-07-02 2002-07-02 Zusammensetzungen enthaltend thylakoids zur modulierung der entzündung
DE60206270T DE60206270T2 (de) 2001-07-02 2002-07-02 Zusammensetzungen enthaltend thylakoids zur modulierung der entzündung
US10/482,797 US7329423B2 (en) 2001-07-02 2002-07-02 Compositions comprising thylakoids useful in the modulation of inflammation process
CA002450833A CA2450833C (fr) 2001-07-02 2002-07-02 Compositions comprenant des thylakoides utiles dans la modulation du processus inflammatoire
JP2003510053A JP4988144B2 (ja) 2001-07-02 2002-07-02 炎症過程の調節に有用なチラコイドを含む組成物
PCT/CA2002/001009 WO2003004042A1 (fr) 2001-07-02 2002-07-02 Compositions comprenant des thylakoides utiles dans la modulation du processus inflammatoire
EP02745002A EP1401463B1 (fr) 2001-07-02 2002-07-02 Compositions comprenant des thylakoides utiles dans la modulation du processus inflammatoire
JP2009221131A JP2009298810A (ja) 2001-07-02 2009-09-25 炎症過程の調節に有用なチラコイドを含む組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002381830A CA2381830A1 (fr) 2002-04-15 2002-04-15 Composes comprenant un extrait de thylakoides pouvant etre utilises pour moduler le processus d'inflammation

Publications (1)

Publication Number Publication Date
CA2381830A1 true CA2381830A1 (fr) 2003-10-15

Family

ID=29256163

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002381830A Abandoned CA2381830A1 (fr) 2001-07-02 2002-04-15 Composes comprenant un extrait de thylakoides pouvant etre utilises pour moduler le processus d'inflammation

Country Status (1)

Country Link
CA (1) CA2381830A1 (fr)

Similar Documents

Publication Publication Date Title
Camacho-Barquero et al. Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis
Fukuyama et al. Hypochlorous acid is antipruritic and anti‐inflammatory in a mouse model of atopic dermatitis
Zdařilová et al. Prunella vulgaris extract and rosmarinic acid suppress lipopolysaccharide-induced alteration in human gingival fibroblasts
Lavand'homme et al. Perioperative administration of the α2-adrenoceptor agonist clonidine at the site of nerve injury reduces the development of mechanical hypersensitivity and modulates local cytokine expression
Yang Topical application of fucoidan improves atopic dermatitis symptoms in NC/Nga mice
JP2024096146A (ja) スキンケアのためのラクトバチルス属（Ｌａｃｔｏｂａｃｉｌｌｉ）
Jaworek et al. Melatonin metabolite, N (1)-acetyl-N (1)-formyl-5-methoxykynuramine (AFMK), attenuates acute pancreatitis in the rat: in vivo and in vitro studies
Abdul Sater et al. Combining a β3 adrenergic receptor agonist with alpha‐lipoic acid reduces inflammation in male mice with diet‐induced obesity
Balaha et al. Epimedin A ameliorates DNFB-induced allergic contact dermatitis in mice: Role of NF-κB/NLRP3-driven pyroptosis, Nrf2/HO-1 pathway, and inflammation modulation
EP1401463B1 (fr) Compositions comprenant des thylakoides utiles dans la modulation du processus inflammatoire
FR3015291A1 (fr) Composition antiprurigineuse
US20100292306A1 (en) Compositions And Methods For The Treatment Of Muscular Dystrophy
Jainu et al. Protective role of ascorbic acid isolated from Cissus quadrangularis on NSAID induced toxicity through immunomodulating response and growth factors expression
CA2381830A1 (fr) Composes comprenant un extrait de thylakoides pouvant etre utilises pour moduler le processus d'inflammation
SK87398A3 (en) Use of ginkgo biloba extracts for the preparation of pharmaceutical compositions, and method of cosmetic treatment using a ginkgo biloba extract
Ohnishi et al. Mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2–dependent pathways are essential for CD8+ T cell–mediated airway hyperresponsiveness and inflammation
CA2450833C (fr) Compositions comprenant des thylakoides utiles dans la modulation du processus inflammatoire
Hung et al. Role of acid back-diffusion, glutathione, oxyradical, and histamine in antral hemorrhagic ulcer in rats: The protective effect of lysozyme chloride and antioxidants
RU2741801C2 (ru) Фармацевтическая композиция из личинок Galleria mellonella и способ её получения
CA3135889A1 (fr) Sulfate de dextran dans les dermatoses inflammatoires
Veronesi et al. Neuropeptide denervation alters both the elicitation and induction phases of contact hypersensitivity in mice
KR102298451B1 (ko) 자일로올리고당을 유효성분으로 함유하는 중금속 및 미세 먼지 제거용 화장료 조성물
KR101424105B1 (ko) 봉독을 포함하는 피부 소양증 개선용 조성물
KR102162571B1 (ko) 지골피의 스테로이드 부작용 개선 효과
Gulyaeva et al. Indices of free-radical oxidation of lipids and antiradical protection of the brain—Neurochemical correlates of development of the general adaptation syndrome

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead